🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Self-hypnosis Training for Chronic Pain Management

RecruitingNAAges 18 Years - anyAllCiusss de L'Est de l'Île de Montréal
NCT06279650 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Title: Self-hypnosis training in chronic pain management: A pilot study Our primary objective concerns the effect of hypnosis intervention on change in 24h pain between T0 (pre-intervention) and T4 (3-month follow-up). The secondary objectives concern the effects of the intervention on (i) change in 24h pain between T0 and T5 (6-month follow-up), (ii) changes from T0 in measures of the functional impact of pain, (iii) changes from T0 in anxiety-depression scores and (iv) changes from T0 in quality of life. The study design is a Randomized efficacy pilot study. The study focuses on patients practicing self-hypnosis within HMR groups. The study population is pain clinic patients. The sample size is 60 pain clinic patients. Study duration: February 2024 - December 2024. Center responsible for the study: Centre de Recherche de l'Hôpital Maisonneuve-Rosemont (CR-HMR) - CEMTL, Montreal, Quebe

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Inclusion criteria were to have participated in the past year in the self-hypnosis training program and to agree to take part in these research interviews. * be 18 years of age or older; * have received one of the above diagnoses, confirmed by medical record review or physician confirmation; * report pain that has been present for at least 3 months; * have a pain intensity over the last 24 hours (24h pain) of at least 4 on a Numerical Rating Scale (NRS) from 0 to 10 at baseline; * be able to read, speak and understand French; * have Internet access and be able to participate in a telepractice intervention group and complete online questionnaires. Exclusion Criteria: * have deafness and/or severe cognitive impairment that may impair communication; * have current or recent psychiatric instability (e.g., active suicidal ideation, active delusional or psychotic thoughts) that could interfere with participation, as assessed by a clinical psychologist.
💊

What it tests

  • Self-hypnosis
  • Psycho-education and cognitive Bahavioral therapy (CBT)
📍

Where

1 site
5415 Bd de l'Assomption
Montreal, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy